Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II

Autor: Rachel Hart, Carissa Thornock, Shimpi Bedi, Zsuzsanna Kuklenyik, John T. Melchior, Jay W. Heinecke, Tomas Vaisar, Scott E. Street, Jere P. Segrest, Amy S. Shah, W. Sean Davidson, Noemie Clouet-Foraison, Jay Jerome
Rok vydání: 2021
Předmět:
SEC
size-exclusion chromatography

Apolipoprotein B
Size-exclusion chromatography
Apolipoprotein A-II
APOA2
apolipoprotein A-II

POPC
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

QD415-436
high-density lipoprotein
UC-HDL
HDL isolated by ultracentrifugation

Biochemistry
BS3
bis-(sulfosuccinimidyl) suberate

PC
phosphatidylcholine

chemistry.chemical_compound
HDL subfractions
FPLC
fast protein liquid chromatography

Endocrinology
High-density lipoprotein
Affinity chromatography
LpA-I
lipoproteins with APOA1 and no APOA2

Cholesterylester transfer protein
CETP
cholesteryl ester transfer protein

Particle Size
mass spectrometry
GO
gene ontology

Apolipoprotein A-I
biology
Chemistry
Cholesterol
HDL

APOA1
apolipoprotein A-I

isotope-dilution MS/MS
differential ion mobility analysis
Fast protein liquid chromatography
Cell Biology
LpA-IS
small subfraction of LpA-I

ratchet model
LpA-IL
large subfraction of LpA-I

lipoproteins
size-exclusion chromatography
IAC
immunoaffinity chromatography

composition
biology.protein
Biophysics
Particle
lipids (amino acids
peptides
and proteins)

Research Article
LpA-I/A-II
lipoproteins with APOA1 and APOA2
Zdroj: Journal of Lipid Research
Journal of Lipid Research, Vol 62, Iss, Pp 100099-(2021)
ISSN: 0022-2275
DOI: 10.1016/j.jlr.2021.100099
Popis: Human high-density lipoproteins (HDLs) are a complex mixture of structurally related nanoparticles that perform distinct physiological functions. We previously showed that human HDL containing apolipoprotein A-I (APOA1) but not apolipoprotein A-II (APOA2), designated LpA-I, is composed primarily of two discretely sized populations. Here, we isolated these particles directly from human plasma by antibody affinity chromatography, separated them by high-resolution size-exclusion chromatography and performed a deep molecular characterization of each species. The large and small LpA-I populations were spherical with mean diameters of 109 A and 91 A, respectively. Unexpectedly, isotope dilution MS/MS with [15N]-APOA1 in concert with quantitation of particle concentration by calibrated ion mobility analysis demonstrated that the large particles contained fewer APOA1 molecules than the small particles; the stoichiometries were 3.0 and 3.7 molecules of APOA1 per particle, respectively. MS/MS experiments showed that the protein cargo of large LpA-I particles was more diverse. Human HDL and isolated particles containing both APOA1 and APOA2 exhibit a much wider range and variation of particle sizes than LpA-I, indicating that APOA2 is likely the major contributor to HDL size heterogeneity. We propose a ratchet model based on the trefoil structure of APOA1 whereby the helical cage maintaining particle structure has two “settings”—large and small—that accounts for these findings. This understanding of the determinants of HDL particle size and protein cargo distribution serves as a basis for determining the roles of HDL subpopulations in metabolism and disease states.
Databáze: OpenAIRE